Share Email Print

Proceedings Paper

Scintillating fiber optic dosimeters for breast and prostate brachytherapy
Author(s): L. M. Moutinho; I. F. Castro; H. Freitas; J. Melo; P. Silva; A. Gonçalves; L. Peralta; P. J. Rachinhas; P. C. P. S. Simões; S. Pinto; A. Pereira; J. A. M. Santos; M. Costa; J. F. C. A. Veloso
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Brachytherapy is a radiotherapy modality where the radioactive material is placed close to the tumor, being a common treatment for skin, breast, gynecological and prostate cancers. These treatments can be of low-dose-rate, using isotopes with mean energy of 30 keV, or high-dose-rate, using isotopes such as 192Ir with a mean energy of 380 keV. Currently these treatments are performed in most cases without in-vivo dosimetry for quality control and quality assurance.

We developed a dosimeter using small diameter probes that can be inserted into the patient's body using standard brachytherapy needles. By performing real-time dosimetry in breast and prostate brachytherapy it will be possible to perform real-time dose correction when deviations from the treatment plan are observed.

The dosimeter presented in this work was evaluated in-vitro. The studies consisted in the characterization of the dosimeter with 500 μm diameter sensitive probes (with a BCF-12 scintillating optical fiber) using an inhouse made gelatin breast phantom with a volume of 566 cm3. A breast brachytherapy treatment was simulated considering a tumor volume of 27 cm3 and a prescribed absolute dose of 5 Gy. The dose distribution was determined by the Inverse Planning Simulated Annealing (IPSA) optimization algorithm (ELEKTA).

The dwell times estimated from the experimental measurements are in agreement with the prescribed dwell times, with relative error below 3%. The measured signal-to-noise ratio (SNR) including the stem-effect contribution is below 3%.

Paper Details

Date Published: 28 February 2017
PDF: 9 pages
Proc. SPIE 10058, Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XVII, 100580C (28 February 2017); doi: 10.1117/12.2254397
Show Author Affiliations
L. M. Moutinho, Univ. de Aveiro (Portugal)
NU-RISE (Portugal)
I. F. Castro, Univ. de Aveiro (Portugal)
NU-RISE (Portugal)
H. Freitas, NU-RISE (Portugal)
J. Melo, NU-RISE (Portugal)
P. Silva, NU-RISE (Portugal)
A. Gonçalves, Univ. of Aveiro (Portugal)
L. Peralta, Univ. de Lisboa (Portugal)
LIP-Lisboa (Portugal)
P. J. Rachinhas, Centro Hospitalar e Univ. de Coimbra (Portugal)
P. C. P. S. Simões, Centro Hospitalar e Univ. de Coimbra (Portugal)
S. Pinto, IPO Porto (Portugal)
A. Pereira, IPO Porto (Portugal)
J. A. M. Santos, IPO Porto (Portugal)
Univ. of Porto (Portugal)
M. Costa, Associaçao de Politecnicos do Norte (Portugal)
J. F. C. A. Veloso, Univ. de Aveiro (Portugal)
NU-RISE (Portugal)

Published in SPIE Proceedings Vol. 10058:
Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XVII
Israel Gannot, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?